PocketEdge
← All news

Desk note · industry · Hospitals / healthcare

Medanta’s September-quarter revenue rose a third as its Noida hospital broke even on EBITDA

Global Health Ltd, which runs the Medanta hospital chain, said on 3 November 2026 that consolidated revenue grew about 33.6% year on year in the September quarter while operating EBITDA margin expanded to about 25.2%, with management highlighting strong patient volumes, higher occupancy, and EBITDA breakeven at its Noida cluster.

3 Nov 2026 · 2 min read

Key takeaways

  • •Consolidated revenue rose about 33.6% year on year in Q2 FY27 while operating EBITDA increased about 60.2%, with EBITDA margin at about 25.2% versus a year earlier.
  • •Profit after tax attributable to owners grew about 38.3% in the quarter; management cited volume growth, higher occupancy, and gains in Cluster 2 markets.
  • •The Noida facility reached EBITDA breakeven in the period, a milestone for a newer cluster that had been absorbing start-up costs.

What's going on here?

Global Health Ltd, listed as Medanta, published September-quarter results on 3 November 2026 showing consolidated revenue growth of about 33.6% year on year. Operating EBITDA rose about 60.2%, pushing EBITDA margin to about 25.2%. Profit after tax attributable to owners increased about 38.3%. In its update, the company pointed to strong patient volumes, better occupancy, and performance in its Cluster 2 geographies. It also said its Noida hospital cluster reached EBITDA breakeven during the quarter, meaning operating earnings at that site covered operating costs after earlier ramp-up losses.

What does this mean?

Private hospitals earn when beds fill and when payers accept tariff revisions on procedures and room categories. A one-third revenue jump with a wider EBITDA margin suggests both footfall and mix moved in Medanta’s favour, not a single one-off surgery line. Breakeven at Noida matters because new campuses depress group margins for years; crossing that line frees capital for the next specialty tower rather than endless subsidies from mature Gurugram units. For urban middle-class patients, sustained occupancy at branded chains is one signal that elective procedures, maternity packages, and planned surgeries are still being booked despite higher EMI burdens elsewhere in the household budget.

Why should I care?

If you are comparing health insurance or corporate tie-ups, occupancy and margin trends at large chains hint at whether networks can absorb more cashless volume without cutting corners. Employers renewing group mediclaim should watch whether hospital groups expand bed counts faster than admission growth. Investors in listed hospital names should read cluster-wise EBITDA disclosures and capex on new brownfield wings rather than day-one share reactions. Watch Medanta’s occupancy metrics on the next call, progress at other newer clusters, and whether tariff hikes stick after regulatory scrutiny on billing.

More desk notes

Disclaimer

For informational purposes only. Not investment advice. Verify with filings and a licensed adviser.